EUVIMEDEUVIMED entdecken
Crossref

Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer

Kenjiro Tsuruoka, Yosuke Tamura, Yasuyuki Shimazu, Masahiro Arai, Sho Mitsuya, Tomoya Funamoto, Hiroyuki Tsuji, Ninso Matsunaga, Takahiko Nakamura, Soichiro Ikeda, Shigeru Kawabata, Akihisa Imagawa und 1 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Kenjiro Tsuruoka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan; kenjirou.tsuruoka@ompu.ac.jp. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, B7-H1 Antigen, Lung Neoplasms, Antineoplastic Combined Chemotherapy Protocols.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaB7-H1 AntigenLung NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleAgedMiddle AgedRetrospective StudiesCarboplatinImmunotherapyAntibodies, Monoclonal, HumanizedAged, 80 and overEtoposideNeoplasm StagingTreatment OutcomeProgression-Free SurvivalAdult

Stichwörter der Autor:innen

Small cell lung cancerimmune checkpoint inhibitor (ICI)programmed cell death protein 1 (PD-1)programmed death-ligand 1 (PD-L1)

Substanzen

B7-H1 AntigenCD274 protein, humanCarboplatinatezolizumabAntibodies, Monoclonal, HumanizedEtoposide

Autor:innen und Institutionen

  • Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan; kenjirou.tsuruoka@ompu.ac.jp.
  • Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Clinical Research Center, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Pathology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Medical Oncology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.

Zitieren

APA

Tsuruoka, K., Tamura, Y., Shimazu, Y., Arai, M., Mitsuya, S., Funamoto, T., Tsuji, H., Matsunaga, N., Nakamura, T., Ikeda, S., Kawabata, S., Imagawa, A., & Fujisaka, Y. (2024). Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17379

Vancouver

Tsuruoka K, Tamura Y, Shimazu Y, Arai M, Mitsuya S, Funamoto T, et al. Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17379

BibTeX
@article{Tsuruoka2024,
  author = {Tsuruoka, Kenjiro and Tamura, Yosuke and Shimazu, Yasuyuki and Arai, Masahiro and Mitsuya, Sho and Funamoto, Tomoya and Tsuji, Hiroyuki and Matsunaga, Ninso and Nakamura, Takahiko and Ikeda, Soichiro and Kawabata, Shigeru and Imagawa, Akihisa and Fujisaka, Yasuhito},
  title = {Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17379}
}
Kostenlos starten →